Come and join us across the globe
Sign In

Predicting the unpredictable course of events after a Flow Diverter placement

Last update on May 16, 2023

Discover the case of a 47-year-old male patient who presented with sudden onset headache and vomiting, only to be diagnosed with bilateral wide complex MCA bifurcation and left para-ophthalmic aneurysm. With his history of chronic smoking, hypertension, HCV reactivity, IV drug abuse, and opium addiction, managing his case proved to be an unstoppable complexity. 

Case presentation

Patient presentation

  • 47-year-old male patient
  • HTN, Chronic smoker
  • HCV reactive, IV drug abuser/ Opium addict
  • Sudden onset headache and vomiting, HH2
  • On examination :
    • GCS E4V5M6, No focal deficit

 

patient-prez

 

patient-prez2

 

B/L wide complex MCA bifurcation and left para-ophthalmic aneurysm

Preferred Approach to be considered:

  • Which one likely ruptured?
  • Which side to treat FIRST?
  • Should both be treated?

 

Treatment Options to be considered:

  • Balloon-assisted coiling?
  • Stent-assisted coiling?
  • Flow diverter stent ALONE / WITH coiling?
  • Surgical clipping?
  • Surgical + Endovascular

 

We considered stent-assisted coiling on right side and coated flow diverter stent for left side in same sitting.

Loaded 2 hours prior with Tablet Ecosprin 150 mg And Tablet Ticagrelor 180 mg

 

Stent-assisted coiling for right MCA Bifurcation aneurysm

  • Clot formation after 5 minutes

 

 

Was it related to Smoking/Opium use?

  • I/A 5mg Abciximab bolus + 7 mg slow injection over 15-20 minutes was given

 

 

Our Patient likely had resistance
  1. Should we still do FD stent on left side?
  2. Wait for a day or two?
  3. Choose alternative options or
  4. Leave and treat on follow up
Intervention

Intervention

  • We decided to treat with coated flow diverter stent for left MCA bifurcation aneurysm

 

mca-bif-aneur

 

On Day 7 since ictus

  • Patient developed transient right hemiparesis with complete recovery in 10 minutes
  • Underwent Urgent CT followed by check DSA to rule out spasm.
  • Severe vasospasm on left side.
  • Chemical dilatation with I/A Nimodipine 3mg + Milrinone 8mg over 45-50 min done
  • Post-dilatation: FD ? Fish mouthing of proximal end causing migration in ICA

 

post-dilatation

 

  • There was minimal spasm on right side.
  • Considering clinical status, spasm and small basal ganglia infarct, option for I/A abciximab was deferred.
  • Patient was shifted to ICU with IV Milrinone infusion @ 15ml/hr

 

Next day morning (Day 8)

  • Patient developed right hemiparesis with facial involvement and aphasia.
  • GCS – E2M5V1, restless, Power on right side UL 1/5 & LL 2/5
  • Underwent check angiography / chemical Dilatation

 

severe-vasospasm

 

  • Severe vasospasm

 

Day 8 evening: long segment CLOT

  • Post dilatation, patient showed partial improvement in motor power.
  • No improvement in speech
  • GCS E2M5V1,
  • Continued with IV Milrinone infusion @15ml/hr.
  • Planned to re-asses and do check DSA in the same day evening

 

long-segment-clot

 

  • Patient was having persistent clot formation and spasm on LEFT side only.
  • Now, we decided to put an overlapping stent from Left M1 MCA to ICA.

 

 

  • But, not able to cross wire through ICA

 

 

  • Limited flow through ACOM

 

 

  • Retrograde transcirculation navigation across Acom artery across FDS and overlapping laser cut stent placement
  • Deployed laser cut self-expanding stent 4.0 x 21 mm from M1 MCA to A1 ACA

 

improvment

 

  • On subsequent runs, spasm improved and clot subsided

 

  • In view of resistant angiographic spasm and clinical deterioration, We decided for continuous I/A chemical dilatation in same sitting.
  • I/A Nimodipine 80mg + Milrinone 40mg @ 10-12 drops/min was started.
  • Started on Abciximab infusion as per body weight and switched to Prasugrel
  • Also started Inj. Enoxaparin 0.6 ml S/C OD.
  • Post-procedure CT showed no fresh bleed
  • GCS after 1 hour – E3M6dullV3

 

Day 12, morning

  • Patient remained clinically stable throughout continuous dilatation.
  • Check DSA done on Day 12, morning
  • No CLOT

 

no-clot

 

  • Patient remained neurologically same with GCS - E3M6dullV3.
  • Patient continued on triple therapy. (Ecosprin 150mg+ Prasugrel 10mg – Inj. Enoxaparin 0.6 S/C OD.
  • Check DSA done on next day (Day-13) to assess clot/spasm.

 

clot-formation

 

Persistent CLOT formation noted

  • We gave Inj. Abciximab 5mg bolus + 7mg slow infusion over 15-20 minutes with subsequent clot resolution.
  • Also, Chemical dilatation was done for moderate vasospasm.
  • Check DSA done on Day 14 to assess clot/spasm, again.

 

We decided not to intervene as patient was neurologically stable, CT showed infarcted tissue and good angiographic leptomeningeal collaterals

 

persistent-clot

 

Conclusion

Treatment options re-visited

  • Many variables to be considered in our case:
    • Opium-induced resistance /
    • Resistant Vasospasm /
    • Flow-dynamics /
    • Reaction to heal /
  • Also, Flow diverter placement in ruptured settings for distal circulation should be considered.
  • Cautious while treating OPIUM addicts with anti-platelets/ anticoagulation.
On the same subject
Come and join us across the globe